Showing results (4851-4860 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|June 12, 2026
Kunxian Capsule Exerts Antitumor Effects by Activating the IL-17 Signaling Pathway to Inhibit the Proliferation, Apoptosis, Cell Cycle, and Induce Reactive Oxygen Species Production in C8166 Tumor CellsXiao-Dan Wang, Xiao-Na Ma, Chun-Sheng Fang, et al.Current Pharmaceutical Design|April 20, 2026
Cubosomes as Versatile Multifunctional Lipid-Based Nanocarriers for Drug Delivery: A Comprehensive ReviewAvinash Tekade, Ashutosh Shewale, H N Shivakumar, et al.Current Pharmaceutical Design|June 1, 2026
Mechanism Analysis of Fuzheng Xiaokui Formula in Treating Recurrent Aphthous Ulcers Based on Network PharmacologyYing Wang, Dan Pan, Tong Shao, et al.Current Pharmaceutical Design|June 2, 2026
Real-World Study on the Efficacy and Safety of Incadronate Disodium in Treating Bone Metastases of Advanced Breast CancerAnjie Zhu, Xinyu Gui, Ruyan Zhang, et al.Current Pharmaceutical Design|June 2, 2026
Emerging Utility of Artificial Intelligence Driven Medical Robots in Health Care: A ReviewPooja V Nagime, Akansha Kamble, Ashwini Kumar, et al.Current Pharmaceutical Design|June 2, 2026
Microbiota-Sensitive Nanocarriers for the Targeted Delivery of Therapeutic Agents into the Gut: Advanced Treatment Strategy for Inflammatory Bowel DiseaseDeepak Kumar, Rishabha Malviya, Sathvik Belagodu Sridhar, et al.Current Pharmaceutical Design|June 2, 2026
Exploring Combination Therapy for the Management of Psychotic Disorders: A Comprehensive ReviewSurbhi Sharma, Dishita Singh Behl, Parul Suri, et al.Current Pharmaceutical Design|June 2, 2026
Network-Based Identification of Ginkgo biloba Targets for Sudden Sensorineural Hearing Loss InterventionQiao Huang, Yi Ren, Ziang Zhu, et al.Current Pharmaceutical Design|June 2, 2026
Transcript-Level Modulation of Drug-Metabolizing Enzymes by Echinacea, Salvia, and Thymus in Adult Male Rats: Implications for Herb-Drug InteractionsShahira H Ahmed, Mohamed M Naguib, Dina M Seoudi, et al.Current Pharmaceutical Design|June 2, 2026
Protopanaxadiol as a Dual-Action Therapeutic Agent: Enhancing Radiotherapy Efficacy and Mitigating DMBA-Induced Breast Cancer through Multi-Target MechanismsAmira Atef Mahmoud, Ibrahim G Abdelrhman, Mohammed Abdalla Hussein, et al.Pageof 1,008